Avian Influenza Vaccines Market
1 Avian Influenza Vaccines Market Overview
1.1 Product Overview and Scope of Avian Influenza Vaccines
1.2 Avian Influenza Vaccines Segment by Type
1.2.1 Global Avian Influenza Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 H5+H7 Avian Influenza Vaccines
1.2.3 H9 Avian Influenza Vaccines
1.3 Avian Influenza Vaccines Segment by Application
1.3.1 Global Avian Influenza Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Chicken Avian Influenza Vaccines
1.3.3 Duck & Goose Avian Influenza Vaccines
1.3.4 Other
1.4 Global Avian Influenza Vaccines Market Size Estimates and Forecasts
1.4.1 Global Avian Influenza Vaccines Revenue 2016-2027
1.4.2 Global Avian Influenza Vaccines Sales 2016-2027
1.4.3 Avian Influenza Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027
2 Avian Influenza Vaccines Market Competition by Manufacturers
2.1 Global Avian Influenza Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Avian Influenza Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Avian Influenza Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Avian Influenza Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Avian Influenza Vaccines Market Competitive Situation and Trends
2.5.1 Avian Influenza Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Avian Influenza Vaccines Players Market Share by Revenue
2.5.3 Global Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Avian Influenza Vaccines Retrospective Market Scenario by Region
3.1 Global Avian Influenza Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Avian Influenza Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Avian Influenza Vaccines Market Facts & Figures by Country
3.3.1 North America Avian Influenza Vaccines Sales by Country
3.3.2 North America Avian Influenza Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Avian Influenza Vaccines Market Facts & Figures by Country
3.4.1 Europe Avian Influenza Vaccines Sales by Country
3.4.2 Europe Avian Influenza Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Avian Influenza Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Avian Influenza Vaccines Sales by Region
3.5.2 Asia Pacific Avian Influenza Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Avian Influenza Vaccines Market Facts & Figures by Country
3.6.1 Latin America Avian Influenza Vaccines Sales by Country
3.6.2 Latin America Avian Influenza Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Avian Influenza Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Avian Influenza Vaccines Sales by Country
3.7.2 Middle East and Africa Avian Influenza Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Avian Influenza Vaccines Historic Market Analysis by Type
4.1 Global Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Avian Influenza Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Avian Influenza Vaccines Price by Type (2016-2021)
5 Global Avian Influenza Vaccines Historic Market Analysis by Application
5.1 Global Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Avian Influenza Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Avian Influenza Vaccines Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Merial
6.1.1 Merial Corporation Information
6.1.2 Merial Description and Business Overview
6.1.3 Merial Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merial Avian Influenza Vaccines Product Portfolio
6.1.5 Merial Recent Developments/Updates
6.2 QYH Biotech
6.2.1 QYH Biotech Corporation Information
6.2.2 QYH Biotech Description and Business Overview
6.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 QYH Biotech Avian Influenza Vaccines Product Portfolio
6.2.5 QYH Biotech Recent Developments/Updates
6.3 DHN
6.3.1 DHN Corporation Information
6.3.2 DHN Description and Business Overview
6.3.3 DHN Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 DHN Avian Influenza Vaccines Product Portfolio
6.3.5 DHN Recent Developments/Updates
6.4 HVRI
6.4.1 HVRI Corporation Information
6.4.2 HVRI Description and Business Overview
6.4.3 HVRI Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 HVRI Avian Influenza Vaccines Product Portfolio
6.4.5 HVRI Recent Developments/Updates
6.5 CEVA
6.5.1 CEVA Corporation Information
6.5.2 CEVA Description and Business Overview
6.5.3 CEVA Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 CEVA Avian Influenza Vaccines Product Portfolio
6.5.5 CEVA Recent Developments/Updates
6.6 Elanco (Lohmann )
6.6.1 Elanco (Lohmann ) Corporation Information
6.6.2 Elanco (Lohmann ) Description and Business Overview
6.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Elanco (Lohmann ) Avian Influenza Vaccines Product Portfolio
6.6.5 Elanco (Lohmann ) Recent Developments/Updates
6.7 Yebio
6.6.1 Yebio Corporation Information
6.6.2 Yebio Description and Business Overview
6.6.3 Yebio Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Yebio Avian Influenza Vaccines Product Portfolio
6.7.5 Yebio Recent Developments/Updates
6.8 Zoetis
6.8.1 Zoetis Corporation Information
6.8.2 Zoetis Description and Business Overview
6.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Zoetis Avian Influenza Vaccines Product Portfolio
6.8.5 Zoetis Recent Developments/Updates
6.9 FATRO
6.9.1 FATRO Corporation Information
6.9.2 FATRO Description and Business Overview
6.9.3 FATRO Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 FATRO Avian Influenza Vaccines Product Portfolio
6.9.5 FATRO Recent Developments/Updates
6.10 Kyoto Biken
6.10.1 Kyoto Biken Corporation Information
6.10.2 Kyoto Biken Description and Business Overview
6.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Kyoto Biken Avian Influenza Vaccines Product Portfolio
6.10.5 Kyoto Biken Recent Developments/Updates
6.11 CAVAC
6.11.1 CAVAC Corporation Information
6.11.2 CAVAC Avian Influenza Vaccines Description and Business Overview
6.11.3 CAVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 CAVAC Avian Influenza Vaccines Product Portfolio
6.11.5 CAVAC Recent Developments/Updates
6.12 Ringpu Biology
6.12.1 Ringpu Biology Corporation Information
6.12.2 Ringpu Biology Avian Influenza Vaccines Description and Business Overview
6.12.3 Ringpu Biology Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Ringpu Biology Avian Influenza Vaccines Product Portfolio
6.12.5 Ringpu Biology Recent Developments/Updates
6.13 Vaksindo
6.13.1 Vaksindo Corporation Information
6.13.2 Vaksindo Avian Influenza Vaccines Description and Business Overview
6.13.3 Vaksindo Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Vaksindo Avian Influenza Vaccines Product Portfolio
6.13.5 Vaksindo Recent Developments/Updates
6.14 ChengDu Tecbond
6.14.1 ChengDu Tecbond Corporation Information
6.14.2 ChengDu Tecbond Avian Influenza Vaccines Description and Business Overview
6.14.3 ChengDu Tecbond Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.14.4 ChengDu Tecbond Avian Influenza Vaccines Product Portfolio
6.14.5 ChengDu Tecbond Recent Developments/Updates
6.15 Sindh Poultry Vaccine Centre
6.15.1 Sindh Poultry Vaccine Centre Corporation Information
6.15.2 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Description and Business Overview
6.15.3 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product Portfolio
6.15.5 Sindh Poultry Vaccine Centre Recent Developments/Updates
6.16 Merck Animal Health
6.16.1 Merck Animal Health Corporation Information
6.16.2 Merck Animal Health Avian Influenza Vaccines Description and Business Overview
6.16.3 Merck Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Merck Animal Health Avian Influenza Vaccines Product Portfolio
6.16.5 Merck Animal Health Recent Developments/Updates
6.17 Medion
6.17.1 Medion Corporation Information
6.17.2 Medion Avian Influenza Vaccines Description and Business Overview
6.17.3 Medion Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Medion Avian Influenza Vaccines Product Portfolio
6.17.5 Medion Recent Developments/Updates
6.18 Avimex Animal Health
6.18.1 Avimex Animal Health Corporation Information
6.18.2 Avimex Animal Health Avian Influenza Vaccines Description and Business Overview
6.18.3 Avimex Animal Health Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Avimex Animal Health Avian Influenza Vaccines Product Portfolio
6.18.5 Avimex Animal Health Recent Developments/Updates
6.19 JOVAC
6.19.1 JOVAC Corporation Information
6.19.2 JOVAC Avian Influenza Vaccines Description and Business Overview
6.19.3 JOVAC Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.19.4 JOVAC Avian Influenza Vaccines Product Portfolio
6.19.5 JOVAC Recent Developments/Updates
6.20 Bio-Labs
6.20.1 Bio-Labs Corporation Information
6.20.2 Bio-Labs Avian Influenza Vaccines Description and Business Overview
6.20.3 Bio-Labs Avian Influenza Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Bio-Labs Avian Influenza Vaccines Product Portfolio
6.20.5 Bio-Labs Recent Developments/Updates
7 Avian Influenza Vaccines Manufacturing Cost Analysis
7.1 Avian Influenza Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Avian Influenza Vaccines
7.4 Avian Influenza Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Avian Influenza Vaccines Distributors List
8.3 Avian Influenza Vaccines Customers
9 Avian Influenza Vaccines Market Dynamics
9.1 Avian Influenza Vaccines Industry Trends
9.2 Avian Influenza Vaccines Growth Drivers
9.3 Avian Influenza Vaccines Market Challenges
9.4 Avian Influenza Vaccines Market Restraints
10 Global Market Forecast
10.1 Avian Influenza Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Avian Influenza Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Avian Influenza Vaccines by Type (2022-2027)
10.2 Avian Influenza Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Avian Influenza Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Avian Influenza Vaccines by Application (2022-2027)
10.3 Avian Influenza Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Avian Influenza Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Avian Influenza Vaccines by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Avian Influenza Vaccines Sales (M Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Avian Influenza Vaccines Sales (M Doses) Comparison by Application (2021-2027)
Table 3. Global Avian Influenza Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Avian Influenza Vaccines Covered in This Study
Table 5. Global Avian Influenza Vaccines Sales (M Doses) of Key Manufacturers (2016-2021)
Table 6. Global Avian Influenza Vaccines Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Avian Influenza Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Avian Influenza Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Avian Influenza Vaccines Average Price (USD/K Doses) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Avian Influenza Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Avian Influenza Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Avian Influenza Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Avian Influenza Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Avian Influenza Vaccines Sales by Region (2016-2021) & (M Doses)
Table 16. Global Avian Influenza Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Avian Influenza Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 19. North America Avian Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Avian Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Avian Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 23. Europe Avian Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Avian Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Avian Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Avian Influenza Vaccines Sales by Region (2016-2021) & (M Doses)
Table 27. Asia Pacific Avian Influenza Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Avian Influenza Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Avian Influenza Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 31. Latin America Avian Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Avian Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Avian Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Avian Influenza Vaccines Sales by Country (2016-2021) & (M Doses)
Table 35. Middle East and Africa Avian Influenza Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Avian Influenza Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Avian Influenza Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Avian Influenza Vaccines Sales (M Doses) by Type (2016-2021)
Table 39. Global Avian Influenza Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Avian Influenza Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Avian Influenza Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Avian Influenza Vaccines Price (USD/K Doses) by Type (2016-2021)
Table 43. Global Avian Influenza Vaccines Sales (M Doses) by Application (2016-2021)
Table 44. Global Avian Influenza Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Avian Influenza Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Avian Influenza Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Avian Influenza Vaccines Price (USD/K Doses) by Application (2016-2021)
Table 48. Merial Corporation Information
Table 49. Merial Description and Business Overview
Table 50. Merial Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 51. Merial Avian Influenza Vaccines Product
Table 52. Merial Recent Developments/Updates
Table 53. QYH Biotech Corporation Information
Table 54. QYH Biotech Description and Business Overview
Table 55. QYH Biotech Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 56. QYH Biotech Avian Influenza Vaccines Product
Table 57. QYH Biotech Recent Developments/Updates
Table 58. DHN Corporation Information
Table 59. DHN Description and Business Overview
Table 60. DHN Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 61. DHN Avian Influenza Vaccines Product
Table 62. DHN Recent Developments/Updates
Table 63. HVRI Corporation Information
Table 64. HVRI Description and Business Overview
Table 65. HVRI Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 66. HVRI Avian Influenza Vaccines Product
Table 67. HVRI Recent Developments/Updates
Table 68. CEVA Corporation Information
Table 69. CEVA Description and Business Overview
Table 70. CEVA Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 71. CEVA Avian Influenza Vaccines Product
Table 72. CEVA Recent Developments/Updates
Table 73. Elanco (Lohmann ) Corporation Information
Table 74. Elanco (Lohmann ) Description and Business Overview
Table 75. Elanco (Lohmann ) Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 76. Elanco (Lohmann ) Avian Influenza Vaccines Product
Table 77. Elanco (Lohmann ) Recent Developments/Updates
Table 78. Yebio Corporation Information
Table 79. Yebio Description and Business Overview
Table 80. Yebio Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 81. Yebio Avian Influenza Vaccines Product
Table 82. Yebio Recent Developments/Updates
Table 83. Zoetis Corporation Information
Table 84. Zoetis Description and Business Overview
Table 85. Zoetis Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 86. Zoetis Avian Influenza Vaccines Product
Table 87. Zoetis Recent Developments/Updates
Table 88. FATRO Corporation Information
Table 89. FATRO Description and Business Overview
Table 90. FATRO Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 91. FATRO Avian Influenza Vaccines Product
Table 92. FATRO Recent Developments/Updates
Table 93. Kyoto Biken Corporation Information
Table 94. Kyoto Biken Description and Business Overview
Table 95. Kyoto Biken Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 96. Kyoto Biken Avian Influenza Vaccines Product
Table 97. Kyoto Biken Recent Developments/Updates
Table 98. CAVAC Corporation Information
Table 99. CAVAC Description and Business Overview
Table 100. CAVAC Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 101. CAVAC Avian Influenza Vaccines Product
Table 102. CAVAC Recent Developments/Updates
Table 103. Ringpu Biology Corporation Information
Table 104. Ringpu Biology Description and Business Overview
Table 105. Ringpu Biology Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 106. Ringpu Biology Avian Influenza Vaccines Product
Table 107. Ringpu Biology Recent Developments/Updates
Table 108. Vaksindo Corporation Information
Table 109. Vaksindo Description and Business Overview
Table 110. Vaksindo Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 111. Vaksindo Avian Influenza Vaccines Product
Table 112. Vaksindo Recent Developments/Updates
Table 113. ChengDu Tecbond Corporation Information
Table 114. ChengDu Tecbond Description and Business Overview
Table 115. ChengDu Tecbond Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 116. ChengDu Tecbond Avian Influenza Vaccines Product
Table 117. ChengDu Tecbond Recent Developments/Updates
Table 118. Sindh Poultry Vaccine Centre Corporation Information
Table 119. Sindh Poultry Vaccine Centre Description and Business Overview
Table 120. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 121. Sindh Poultry Vaccine Centre Avian Influenza Vaccines Product
Table 122. Sindh Poultry Vaccine Centre Recent Developments/Updates
Table 123. Merck Animal Health Corporation Information
Table 124. Merck Animal Health Description and Business Overview
Table 125. Merck Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 126. Merck Animal Health Avian Influenza Vaccines Product
Table 127. Merck Animal Health Recent Developments/Updates
Table 128. Medion Corporation Information
Table 129. Medion Description and Business Overview
Table 130. Medion Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 131. Medion Avian Influenza Vaccines Product
Table 132. Medion Recent Developments/Updates
Table 133. Avimex Animal Health Corporation Information
Table 134. Avimex Animal Health Description and Business Overview
Table 135. Avimex Animal Health Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 136. Avimex Animal Health Avian Influenza Vaccines Product
Table 137. Avimex Animal Health Recent Developments/Updates
Table 138. JOVAC Corporation Information
Table 139. JOVAC Description and Business Overview
Table 140. JOVAC Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 141. JOVAC Avian Influenza Vaccines Product
Table 142. JOVAC Recent Developments/Updates
Table 143. Bio-Labs Corporation Information
Table 144. Bio-Labs Description and Business Overview
Table 145. Bio-Labs Avian Influenza Vaccines Sales (M Doses), Revenue (Million US$), Price (USD/K Doses) and Gross Margin (2016-2021)
Table 146. Bio-Labs Avian Influenza Vaccines Product
Table 147. Bio-Labs Recent Developments/Updates
Table 148. Production Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Avian Influenza Vaccines Distributors List
Table 151. Avian Influenza Vaccines Customers List
Table 152. Avian Influenza Vaccines Market Trends
Table 153. Avian Influenza Vaccines Growth Drivers
Table 154. Avian Influenza Vaccines Market Challenges
Table 155. Avian Influenza Vaccines Market Restraints
Table 156. Global Avian Influenza Vaccines Sales Forecast by Type (2022-2027) & (M Doses)
Table 157. Global Avian Influenza Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 158. Global Avian Influenza Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 159. Global Avian Influenza Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 160. Global Avian Influenza Vaccines Sales Forecast by Application (2022-2027) & (M Doses)
Table 161. Global Avian Influenza Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 162. Global Avian Influenza Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 163. Global Avian Influenza Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 164. Global Avian Influenza Vaccines Sales Forecast by Region (2022-2027) & (M Doses)
Table 165. Global Avian Influenza Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 166. Global Avian Influenza Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 167. Global Avian Influenza Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Avian Influenza Vaccines
Figure 2. Global Avian Influenza Vaccines Market Share by Type in 2020 & 2027
Figure 3. H5+H7 Avian Influenza Vaccines Product Picture
Figure 4. H9 Avian Influenza Vaccines Product Picture
Figure 5. Global Avian Influenza Vaccines Market Share by Application in 2020 & 2027
Figure 6. Chicken Avian Influenza Vaccines
Figure 7. Duck & Goose Avian Influenza Vaccines
Figure 8. Other
Figure 9. Global Avian Influenza Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Avian Influenza Vaccines Market Size 2016-2027 (US$ Million)
Figure 11. Global Avian Influenza Vaccines Sales 2016-2027 (M Doses)
Figure 12. Global Avian Influenza Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 13. Avian Influenza Vaccines Sales Share by Manufacturers in 2020
Figure 14. Global Avian Influenza Vaccines Revenue Share by Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Avian Influenza Vaccines Players: Market Share by Revenue in 2020
Figure 16. Avian Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 17. Global Avian Influenza Vaccines Sales Market Share by Region (2016-2021)
Figure 18. Global Avian Influenza Vaccines Sales Market Share by Region in 2020
Figure 19. Global Avian Influenza Vaccines Revenue Market Share by Region (2016-2021)
Figure 20. Global Avian Influenza Vaccines Revenue Market Share by Region in 2020
Figure 21. U.S. Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Canada Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Germany Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. France Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. U.K. Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Italy Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Russia Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. China Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Japan Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. South Korea Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. India Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Australia Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Taiwan Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Indonesia Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Thailand Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Malaysia Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Mexico Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Brazil Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Argentina Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Turkey Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Saudi Arabia Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. UAE Avian Influenza Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Sales Market Share of Avian Influenza Vaccines by Type (2016-2021)
Figure 44. Sales Market Share of Avian Influenza Vaccines by Application (2016-2021)
Figure 45. Sales Market Share of Avian Influenza Vaccines by Application in 2020
Figure 46. Revenue Share of Avian Influenza Vaccines by Application (2016-2021)
Figure 47. Revenue Share of Avian Influenza Vaccines by Application in 2020
Figure 48. Manufacturing Cost Structure of Avian Influenza Vaccines
Figure 49. Manufacturing Process Analysis of Avian Influenza Vaccines
Figure 50. Avian Influenza Vaccines Industrial Chain Analysis
Figure 51. Channels of Distribution
Figure 52. Distributors Profiles
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Industry Market Size
